Laparoscopic antireflux surgery in the lung transplant population

Surgical Endoscopy and Other Interventional Techniques

Volumn 16, Issue 12, 2002, Pages 1674-1678

  Lau, C L ^a   Palmer, S M ^a   Howell, D N ^a   McMahon, R ^a   Hadjiliadis, D ^a   Gaca, J ^a   Pappas, T N ^a   Davis, R D ^a   Eubanks, S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antireflux surgery; Bronchiolitis obliterans syndrome; Gastroesophageal reflux disease (GERD); Laparoscopic fundoplication; Lung transplantation; Pulmonary disease

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AGED; ANTIREFLUX OPERATION; ARTICLE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LAPAROSCOPIC SURGERY; LAPAROSCOPY; LENGTH OF STAY; LUNG DISEASE; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH FUNDOPLICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BRONCHIOLITIS OBLITERANS; CHILD; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; GRAFT REJECTION; HUMANS; LAPAROSCOPY; LENGTH OF STAY; LUNG; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 0036913534     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-001-8251-2     Document Type: Article

References (22)

1. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo SA, Yousem SA, Close JM, Zeevi A, Duquesnoy RJ (1995) Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management. J Thorac Cardiovasc Surg 110: 4-13
2. Cooper JD, Billingham M, Egan T, Hertz MI, Higenbottam T, Lynch J, Mauer J, Paradis I, Patterson GA, Smith C (1993) A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 12: 713-716
3. Diamond DA, Michalski JM, Lynch JP, Trulock EP (1998) Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation. Int J Rad Oncol 41: 795-800
4. Dusmet M, Maurer J, Winston T, Kesten S (1996) Methotrexate can halt the progression of brochiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 15: 948-954
5. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ (1998) The Registry of the International Society for Heart and Lung Transplantation: Fifteenth official report. J Heart Lung Transplant 17: 656-668
6. Iacono AT, Keenan R, Duncan SR, Smaldone GC, Dauber JH, Paradis IL, Ohori NP, Grgurich WF, Burckart GJ, Zeevi Aet al.et al. (1996) Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am J Respir Crit Care Med 153: 1451-1455
7. Kelly K, Hertz MI (1997) Obliterative bronchiolitis. Clin Chest Med 18: 319-338
8. Kesten S, Chaparro C, Scavuzzo M, Gutierrez C (1997) Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. J Heart Lung Transplant 16: 905-912
9. Kesten S, Rajagopalan N, Maurer J (1996) Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation. Transplant 61: 427-430
10. Lau CL, Palmer SM, Posther KE, Howell DN, Reinsmoen NL, Massey HT, Tapson VF, Jaggers JJ, D'Amico TA, Davis Jr RD (2000) Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. Ann Thorac Surg 69: 1520-1524
11. Palmer SM, Hadjiliadis D, Eubanks WS, Tapson VF, Brazer SR, Lawrence CM, Rea J, Davis RD (2001) Impact of early fundoplication surgery on pulmonary function in lung transplant recipients with gastroesophageal reflux. Am J Respir Crit Care Med 163: A325
12. Palmer SM, Miralles AP, Howell DN, Brazer SR, Tapson VF, Davis RD (2000) Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest 118: 1214-1217
13. Palmer SM, Steele MP, Miralles AP, Lawrence C, Petersen A, D'Amico TD, Davis RD, Tapson VF (1999) Gastroesophageal reflux is an important cause of allograft dysfunction in lung transplant recipients. J Heart Lung Transplant 18: 51A
14. Reichenspurner H, Meiser BM, Kur F, Wagner F, Welz A, Uberfuhr P, Briegel H, Reichart B (1995) First experience with FK506 for treatment of chronic pulmonary rejection. Transplant Proc 27: 2009
15. Scott JP, Higgenbottam TW, Sharples L, Clelland CA, Smyth RL, Stewart S, Wallwork J (1991) Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplant 51: 813-817
16. Slovis BS, Loyd JE, King Jr LE (1995) Photopheresis for chronic rejection of lung allografts. New Engl J Med 332: 962
17. Snell GI, Esmore DS, Williams TJ (1996) Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest 109: 874-878
18. Speich R, Boehler A, Russi EW, Weder W (1997) A case report of a double-blind, randomized trial of inhaled steroids in a patient with lung transplant bronchiolitis obliterans. Respiration 64: 375-380
19. Speich R, Boehler A, Thurnheer R, Weder W (1997) Salvage therapy with mycophenolate mofetil for lung transplantation bronchiolitis obliterans: Importance of dosage. Transplant 64: 533-535
20. Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA (1995) Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation: Washington University Lung Transplant Group. Ann Thorac Surg 60: 1341-1346
21. Valentine VG, Robbins RC, Berry GJ, Patel HR, Reichenspurner BA, Reitz BA, Theodore J (1996) Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 15: 371-383
22. Whyte RI, Rossi SJ, Mulligan MS, Florn R, Baker L, Gupta S, Martinez FJ, Lynch 3rd JP (1997) Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation. Ann Thorac Surg 64: 945-948